Exodus Point Capital Management, LP Deciphera Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.58 - $17.36 $2.38 Million - $3.04 Million	-175,195 Reduced 52.16%	160,690 $2.53 Million
Q3 2023 Nov 09, 2023	SELL	$12.46 - $15.48 $2.55 Million - $3.16 Million	-204,431 Reduced 37.84%	335,885 $4.27 Million
Q2 2023 Aug 10, 2023	BUY	$13.28 - $15.96 $1.4 Million - $1.69 Million	105,646 Added 24.3%	540,316 $7.61 Million
Q1 2023 May 11, 2023	SELL	$14.26 - $22.1 $2.07 Million - $3.2 Million	-144,984 Reduced 25.01%	434,670 $6.72 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $4.02 Million - $5.15 Million	270,685 Added 87.61%	579,654 $9.5 Million
Q3 2022 Nov 10, 2022	SELL	$12.38 - $20.23 $631,949 - $1.03 Million	-51,046 Reduced 14.18%	308,969 $5.72 Million
Q2 2022 Aug 19, 2022	BUY	$9.11 - $13.98 $754,854 - $1.16 Million	82,860 Added 29.9%	360,015 $4.73 Million
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $1.9 Million - $3.08 Million	277,155 New	277,155 $2.57 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $549,627 - $771,981	-13,608 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $704,486 - $900,577	13,608 New	13,608 $777,000

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.